Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
38 drugs in development
By Therapeutic Area
top 6
R&D Momentum
100/100
Pipeline Velocity
88/100
Trial Completion Rate
65/100
Pipeline Concentration
34/100
Pipeline Freshness
68/100
Strategic Signals
Activity
Last 14 days
Removing Home Hazards for Older Adults
Tailored, Intervention to Improve Medication Management in Community-Dwelling Older Adults: A Pilot Study
COMPASS: A Novel Transition Program to Reduce Disability After Stroke
The Effectiveness of a Fall Prevention Program
Adapted Lifestyle-integrated Functional Exercise Program for Older Adults in Under Resourced Communities: A Pilot Study
Adapting, Implementing and Evaluating the Effectiveness of the Home Hazard Removal Program for People With Disabilities
Correlating Electroconvulsive Therapy Response to Electroencephalographic Ictal Complexes and Postictal Markers
Evaluating the Feasibility of an Automated Bidet Intervention to Decrease Caregiver Burden
A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder
Building Capacity to Improve Community Participation for People Aging With Long-Term Disability Through Evidence-Based Strategies
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)